SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (9454)12/16/2002 2:20:05 PM
From: tom pope  Respond to of 9719
 
Morgan Stanley weighs in, from Briefing:

Corixa: odds of Bexxar approval may be slipping - Morgan Stanley (6.99 +0.24) -- Update --
Sources are telling us that Morgan Stanley now believes that the odds of CRXA's Bexxar getting approved by the FDA have slipped below 50%; if Bexxar is not approved, competitor IDPH will be the likely beneficiary.